China Mengniu Dairy (2319.HK): Liquid milk enters a cyclical recovery, while non-liquid milk businesses open up additional growth opportunities for Mengniu

Overview

The report focuses on China Mengniu Dairy’s cyclical recovery in liquid milk, expansion of its non-liquid milk businesses, and changes in tax policy. BofA Securities believes that additional near-term tax expenses will reduce its 2026 earnings forecast, but higher revenue guidance, an improving raw milk cycle, diversified business growth, and sustained free cash flow collectively support a medium-term earnings recovery. It therefore reiterates its Buy rating and HKD21.00 target price.

Core views

The report first lowers its 2026 EPS forecast by 4%, from CNY1.24 to CNY1.19, mainly to reflect the additional tax burden arising from the tax reclassification of agricultural products. The 2027 EPS forecast is broadly maintained and currently stands at CNY1.38. BofA Securities believes this adjustment primarily represents a tax impact below the operating profit line and does not alter the operating recovery thesis. It therefore reiterates its Buy rating and HKD21.00 target price. The report emphasizes that the cyclical recovery in liquid milk could continue through at least 2027, while diversification into non-liquid milk businesses may support growth for even longer. Compound growth over the next two to three years is expected to become a key support for valuation and the share price. The company raised its FY2026 operating guidance: its revenue growth target was increased from the previous mid-single digits to high-single digits, with growth remaining strong in July and August. Its core operating margin target was revised from approximately 8%, implying a flat year-over-year result, to no less than 8%, indicating potential for upside surprises. The long-term operating margin target is 9% to 10%. Regarding raw milk, the company expects prices to rise steadily in the second half of 2026 and in 2027, potentially extending into 2028. The report believes this cyclical shift will improve the industry environment and create conditions for liquid milk to gain market share and recover its average selling price. The first-half 2026 results provide operating evidence for this assessment. Group revenue was RMB44.795 billion, up 7.8% year over year. Liquid milk revenue was RMB33.865 billion, up 5.2%, while revenue from ice cream, milk formula, and cheese rose 8.5%, 22.8%, and 32.6%, respectively. The report notes that non-liquid milk businesses contributed more than 50% of incremental revenue, showing that growth no longer depends solely on the recovery in liquid milk. During the same period, gross profit increased 5.2%, while gross margin declined 1.0 percentage point to 40.8%. The selling and administrative expense ratio fell 0.7 percentage points to 31.9%, partially offsetting gross margin pressure. Operating profit increased 2.3% to RMB3.573 billion, while core operating profit rose 3.9% to RMB3.676 billion. Operating margin and core operating margin declined by 0.4 and 0.3 percentage points to 8.0% and 8.2%, respectively. Net profit increased 15.9% to RMB2.371 billion, while core net profit grew 31.6% to RMB2.691 billion, with core net margin rising 1.1 percentage points to 6.0%. For 2027, the company has not yet provided a formal growth forecast, but it has identified two growth drivers: liquid milk growth exceeding the industry rate and continued strength in non-liquid milk businesses such as cheese, milk formula, ice cream, and import substitution. The company believes the latter may contribute more to group growth than liquid milk. On this basis, BofA Securities raised its 2026 revenue forecast by 2.2%, from RMB86.334 billion to RMB88.259 billion, and its 2027 revenue forecast by 2.1%, from RMB90.683 billion to RMB92.617 billion. The 2026 core operating profit forecast was raised 2.4% to RMB7.029 billion, with core operating margin maintained at 8.0%. However, the effective tax rate forecast was increased from 22.0% to 27.0%, resulting in a 3.9% reduction in the net profit forecast to RMB4.672 billion and a decline in net margin from 5.6% to 5.3%. The 2027 net profit forecast is broadly unchanged at RMB5.426 billion, with a core operating margin of 8.2% and an effective tax rate expected to fall back to 23.0%. Adjusted net profit and EPS forecasts for 2028 are RMB5.932 billion and CNY1.51, respectively. Taxation is the principal source of volatility below the operating profit line. China has reclassified certain agricultural products, causing some previously tax-exempt sales to become taxable, with retrospective effects on prior years. The report estimates that the related tax impact will exceed RMB500 million in FY2026 before normalizing to more than RMB200 million in FY2027. Meanwhile, the upward raw milk cycle may drive an earnings recovery at the associate China Modern Dairy and generate fair-value gains on biological assets. Consequently, the expansion in the group’s net margin may exceed the improvement in its operating margin. Cash flow, the balance sheet, and shareholder returns provide another source of support. The report forecasts free cash flow of RMB5.451 billion, RMB6.129 billion, and RMB6.617 billion for 2026 to 2028, respectively, while net debt is projected to decline from RMB12.134 billion in 2025 to RMB8.936 billion, RMB5.694 billion, and RMB2.527 billion. Over the same period, return on equity is expected to rise from 11.3% in 2026 to 12.7% in 2027 and 13.4% in 2028, while net debt-to-equity ratios decline to 18.3%, 11.3%, and 4.9%, respectively. DPS forecasts are CNY0.596, CNY0.761, and CNY0.908, corresponding to dividend yields of 3.70%, 4.73%, and 5.64%. The company also maintained guidance for steady DPS growth and a share repurchase pace similar to that of FY2024/25. Repurchases over the past 12 months totaled approximately HKD500 million. The HKD21.00 target price is derived using an equal 50% weighting of P/E and discounted cash flow valuations. The P/E-based valuation is HKD19.9, applying a 15x 2026 forecast P/E, a 25% discount to the company’s 10-year average valuation to reflect slower long-term trend growth. The discounted cash flow valuation is HKD22.1, based on a weighted average cost of capital of 10.4%, a beta of 0.9, and a terminal growth rate of 2%, while incorporating stronger free cash flow generation. The report’s forecast P/E ratios for 2026 to 2028 are 13.53x, 11.65x, and 10.65x, respectively, while free cash flow yields are 8.62%, 9.70%, and 10.47%. The current price-to-book ratio is 1.5x. Downside risks to the target price include raw milk price trends falling short of expectations, more intense peer competition or adverse changes in the competitive landscape, and a slower-than-expected recovery in sales and margins. Conversely, more favorable raw milk price trends, easing peer competition, or a faster-than-expected recovery in sales and margins could create upside risk to the target price.

Analysis framework

The report first uses first-half 2026 segment revenue, margin, and expense-ratio data to assess the operating recovery, and then combines these findings with the company’s upgraded revenue and margin guidance to evaluate the growth trajectory for 2026 to 2027. It subsequently distinguishes operating factors from below-operating-profit items such as taxes and income from associates when adjusting EPS forecasts. Finally, it validates the financial improvement using cash flow, declining debt, shareholder returns, and profitability metrics, and determines the target price by assigning equal 50% weights to P/E and discounted cash flow valuations.

Methodology notes

• Valuation MethodP/E and PEG Valuation

  2026 Forecast P/E Valuation

  The report applies a 15x 2026 forecast P/E to derive a valuation of HKD19.9. This multiple represents a 25% discount to Mengniu’s 10-year average valuation to reflect slower long-term trend growth.

• Valuation MethodDiscounted Cash Flow Valuation

  Discounted Cash Flow Valuation

  The report discounts future free cash flow and incorporates a terminal value, deriving a valuation of HKD22.1 based on a weighted average cost of capital of 10.4%, a beta of 0.9, and a terminal growth rate of 2%.

• Industry/Sector Analysis FrameworkSupply-demand framework

  Raw Milk Price Cycle Analysis

  The report assesses the dairy industry environment based on changes in raw milk prices from the second half of 2026 through 2027 and potentially 2028, and uses this assessment to analyze the recovery path for liquid milk market share, average selling prices, and earnings from associates.

• Industry/Sector Analysis FrameworkVolume-price decomposition

  Growth Decomposition by Segment Revenue, Market Share, and Average Selling Price

  The report separately examines revenue growth in liquid milk, ice cream, milk formula, and cheese, and combines this with the recovery in liquid milk market share and average selling price to distinguish the contributions of cyclical recovery and business diversification to group growth.

• Company Fundamentals and Financial FrameworkFree cash flow analysis

  Free Cash Flow and Deleveraging Analysis

  The report calculates free cash flow by subtracting capital expenditure from operating cash flow and combines this with the continuing decline in net debt to evaluate the company’s financial capacity to support dividends, share repurchases, and valuation.

• Company Fundamentals and Financial FrameworkEarnings Quality Analysis

  iQmethod Standardized Operating Performance and Earnings Quality Metrics

  The report uses standardized metrics including operating margin, return on capital, return on equity, cash realization ratio, net debt-to-equity ratio, and interest coverage ratio to cross-check earnings improvement, cash conversion, and balance-sheet quality.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• China Mengniu Dairy (2319.HK)

  The report believes the company will benefit from the cyclical recovery in liquid milk, growth in non-liquid milk businesses, cost control, and improved shareholder returns.

  Strengths

  One of China’s leading dairy companies; room for recovery in liquid milk market share and average selling price; rapid growth in cheese, milk formula, and ice cream; stable free cash flow and declining net debt.

  Weaknesses

  Liquid milk still accounts for a high proportion of sales, gross margin faces pressure, and the company is also affected by retrospective taxes in 2026.

  Comparison

  The report expects liquid milk growth to exceed the industry rate and believes that non-liquid milk may contribute more to group growth than liquid milk.

  Risks

  Unfavorable raw milk price trends, intensifying peer competition, and a slower-than-expected recovery in sales and margins.

Key data

• First-Half 2026 RevenueRMB44,795mnUp 7.8% year over year
• First-Half 2026 Net ProfitRMB2,371mnUp 15.9% year over year
• First-Half 2026 Core Net ProfitRMB2,691mnUp 31.6% year over year
• First-Half 2026 Core Operating Margin8.2%Down 0.3 percentage points year over year
• FY2026 Revenue GuidanceHigh-single-digit growthPrevious guidance was for mid-single-digit growth
• Long-Term Operating Margin Target9%-10%The FY2026 core operating margin target is no less than 8%
• 2026 Tax ImpactRMB500mn+Tax reclassification of agricultural products and retrospective impact
• 2027 Tax ImpactRMB200mn+Expected to normalize from the 2026 level
• 2026 EPS ForecastCNY1.19Lowered 4% from CNY1.24
• 2027 EPS ForecastCNY1.38Forecast broadly maintained
• 2026 Revenue ForecastRMB88,259mnRaised 2.2% from the previous forecast
• 2027 Revenue ForecastRMB92,617mnRaised 2.1% from the previous forecast
• Share Repurchases Over the Past 12 MonthsHK$500mnThe company maintained guidance for a repurchase pace similar to that of FY2024/25
• Target PriceHK$21.00P/E and discounted cash flow valuations are each weighted 50%
• P/E ValuationHK$19.9Based on a 15x 2026 forecast P/E, representing a 25% discount to the 10-year average valuation
• Discounted Cash Flow ValuationHK$22.1Based on a 10.4% weighted average cost of capital, a beta of 0.9, and a 2% terminal growth rate

Impact & implications

The report believes Mengniu’s earnings recovery is shifting from a singular cyclical rebound in liquid milk to a combination of improving liquid milk market share and selling prices, rapid growth in non-liquid milk businesses, and expense control. The retrospective tax burden in 2026 will reduce net profit, but if the tax rate normalizes in 2027 while associates benefit from the raw milk cycle, the company’s net margin may improve faster than its operating margin. Stable free cash flow, continued deleveraging, dividend growth, and share repurchases provide further support for medium-term shareholder returns.

Risks

• If raw milk price trends fall short of the report’s expectations, they could weaken the improvement in the industry environment and the recovery in liquid milk selling prices.
• If peer competition intensifies or the competitive landscape changes adversely, market share and margins could be affected.
• If the recovery in sales and margins is slower than expected, it could create downside pressure on the target price.
• More favorable raw milk price trends, easing peer competition, or a faster recovery in sales and margins are the upside risks to the target price identified in the report.

What to watch

• Track whether raw milk prices rise steadily in the second half of 2026 and in 2027, and whether the cycle extends into 2028.
• Monitor whether FY2026 revenue achieves high-single-digit growth and whether core operating margin reaches the target of no less than 8%.
• Watch whether cheese, milk formula, ice cream, and import-substitution businesses continue to contribute more incremental growth than liquid milk.
• Track whether the additional tax impact exceeds RMB500 million in 2026 and declines to a normalized level of more than RMB200 million in 2027.
• Monitor liquid milk market share, average selling price, and the pace of recovery in sales and margins.
• Watch whether DPS growth and share repurchases maintain the pace indicated by the company.